NCT00310115

Brief Summary

RATIONALE: Motivational counseling may help prevent pregnant women from smoking again after pregnancy. PURPOSE: This randomized clinical trial is studying three different types of counseling to see how well they work in preventing smoking relapse after pregnancy in pregnant women who quit smoking during pregnancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
469

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2002

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2002

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 3, 2006

Completed
10.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
Last Updated

September 23, 2016

Status Verified

September 1, 2016

Enrollment Period

14.3 years

First QC Date

March 29, 2006

Last Update Submit

September 21, 2016

Conditions

Keywords

non-small cell lung cancersmall cell lung cancerbladder cancercervical canceresophageal cancergastric cancerrenal cell carcinomaadult primary liver cancerpancreatic cancerhypopharyngeal cancerlip and oral cavity cancerlaryngeal cancernasopharyngeal canceroropharyngeal cancerparanasal sinus and nasal cavity canceradult acute myeloid leukemiatobacco use disorder

Outcome Measures

Primary Outcomes (1)

  • Number of Patients with Smoking Abstinence

    Smoking abstinence as measured by the Society for Research on Nicotine and Tobacco Smoking Status Measure at 26 weeks following study treatment

    26 weeks

Secondary Outcomes (1)

  • Number of Cigarettes Smoked Daily

    26 weeks following study treatment

Study Arms (3)

Smoking Prevention Usual Care

Arm I (usual care): Self-help materials and brief relapse prevention advice based on Treating Tobacco Use and Dependence Clinical Practice Guideline.

Behavioral: Smoking Prevention Usual Care

MRP

Arm II (motivational relapse prevention \[MRP\]): Same intervention as usual care, plus 30 minutes telephone counseling at 34 \& 36 weeks gestation then at 2, 4, 7, \& 16 weeks postpartum.

Behavioral: Smoking Prevention Usual CareBehavioral: Counseling Intervention

Enhanced MRP +

Arm III (enhanced MRP \[MRP+\]): Same intervention as usual care and telephone counseling as MRP, plus 1 hour in-person counseling at 30-33 weeks gestation \& 8 weeks postpartum.

Behavioral: Smoking Prevention Usual CareBehavioral: Counseling Intervention

Interventions

Usual care of self-help materials and advice for staying cigarette free

Enhanced MRP +MRPSmoking Prevention Usual Care

6 x 30 minute counseling sessions over the telephone

Enhanced MRP +MRP

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women, 18 years of age or older, who quit smoking while pregnant.

You may qualify if:

  • age 18 or older
  • former smoker who quit during pregnancy as assessed via self-report
  • smoked an average of greater than or equal to 1 cigarette per day during the year prior to the current pregnancy
  • gestational age \< 33 weeks and ability to attend an in-person visit at University of Texas MD Anderson Cancer Center (UTMDACC) between 30-33 weeks of gestational age
  • can speak, read and write in English.
  • must have a functioning home or personal cell phone

You may not qualify if:

  • \) high-risk pregnancy or known negative birth outcome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030-4009, United States

Location

Related Links

MeSH Terms

Conditions

Urinary Bladder NeoplasmsUterine Cervical NeoplasmsEsophageal NeoplasmsStomach NeoplasmsHead and Neck NeoplasmsKidney NeoplasmsLeukemiaLiver NeoplasmsLung NeoplasmsPancreatic NeoplasmsTobacco Use DisorderCarcinoma, Non-Small-Cell LungSmall Cell Lung CarcinomaCarcinoma, Renal CellCarcinoma, HepatocellularHypopharyngeal NeoplasmsMouth NeoplasmsLaryngeal NeoplasmsNasopharyngeal NeoplasmsOropharyngeal NeoplasmsLeukemia, Myeloid, Acute

Interventions

Counseling

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesUterine NeoplasmsGenital Neoplasms, FemaleUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleGenital DiseasesGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesStomach DiseasesKidney DiseasesNeoplasms by Histologic TypeHematologic DiseasesHemic and Lymphatic DiseasesLiver DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesEndocrine Gland NeoplasmsPancreatic DiseasesEndocrine System DiseasesSubstance-Related DisordersChemically-Induced DisordersMental DisordersCarcinoma, BronchogenicBronchial NeoplasmsAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic DiseasesMouth DiseasesLaryngeal DiseasesNasopharyngeal DiseasesLeukemia, Myeloid

Intervention Hierarchy (Ancestors)

Mental Health ServicesBehavioral Disciplines and ActivitiesCommunity Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • David Wetter, PhD, BS, BA

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2006

First Posted

April 3, 2006

Study Start

April 1, 2002

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 23, 2016

Record last verified: 2016-09

Locations